BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 19435961)

  • 1. Basal-state hyperinsulinemia in healthy normoglycemic adults is predictive of type 2 diabetes over a 24-year follow-up: a preliminary report.
    Dankner R; Chetrit A; Shanik MH; Raz I; Roth J
    Diabetes Care; 2009 Aug; 32(8):1464-6. PubMed ID: 19435961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basal state hyperinsulinemia in healthy normoglycemic adults heralds dysglycemia after more than two decades of follow up.
    Dankner R; Chetrit A; Shanik MH; Raz I; Roth J
    Diabetes Metab Res Rev; 2012 Oct; 28(7):618-24. PubMed ID: 22865584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive risk factors for deterioration from normoglycemic state to type 2 diabetes mellitus or impaired glucose tolerance in a Tunisian urban population.
    Chihaoui M; Kanoun F; Ben Rehaiem B; Ben Brahim S; Ftouhi B; Mekaouar A; Fekih M; Mbazâd A; Zouari B; Ben Khalifa F
    Diabetes Metab; 2001 Sep; 27(4 Pt 1):487-95. PubMed ID: 11547223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of genetic prediabetic south Indian subjects. Importance of hyperinsulinemia and beta-cell dysfunction.
    Snehalatha C; Ramachandran A; Satyavani K; Latha E; Viswanathan V
    Diabetes Care; 1998 Jan; 21(1):76-9. PubMed ID: 9538973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired glucose tolerance is a more advanced stage of alteration in the glucose metabolism than impaired fasting glucose.
    Guerrero-Romero F; Rodríguez-Morán M
    J Diabetes Complications; 2001; 15(1):34-7. PubMed ID: 11259924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identical anthropometric characteristics of impaired fasting glucose combined with impaired glucose tolerance and newly diagnosed type 2 diabetes: anthropometric indicators to predict hyperglycaemia in a community-based prospective cohort study in southwest China.
    Zhang F; Wan Q; Cao H; Tang L; Li D; Lü Q; Yan Z; Li J; Yang Q; Zhang Y; Tong N
    BMJ Open; 2018 May; 8(5):e019735. PubMed ID: 29743321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study.
    Kabootari M; Hasheminia M; Azizi F; Mirbolouk M; Hadaegh F
    Cardiovasc Diabetol; 2020 Mar; 19(1):41. PubMed ID: 32228577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of traits of metabolic syndrome with glucose abnormalities.
    Hoffmann IS; Cubeddu LX
    Am J Ther; 2013; 20(4):363-8. PubMed ID: 23591026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Features of the metabolic syndrome predict higher risk of diabetes and impaired glucose tolerance: a prospective study in Mauritius.
    Boyko EJ; de Courten M; Zimmet PZ; Chitson P; Tuomilehto J; Alberti KG
    Diabetes Care; 2000 Sep; 23(9):1242-8. PubMed ID: 10977013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of acanthosis nigricans with hyperinsulinemia compared with other selected risk factors for type 2 diabetes in Cherokee Indians: the Cherokee Diabetes Study.
    Stoddart ML; Blevins KS; Lee ET; Wang W; Blackett PR;
    Diabetes Care; 2002 Jun; 25(6):1009-14. PubMed ID: 12032107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies.
    Gerstein HC; Santaguida P; Raina P; Morrison KM; Balion C; Hunt D; Yazdi H; Booker L
    Diabetes Res Clin Pract; 2007 Dec; 78(3):305-12. PubMed ID: 17601626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of impaired fasting glucose, healthcare utilization and progression to diabetes in the UK using the Clinical Practice Research Datalink (CPRD).
    Hong JL; McNeill AM; He J; Chen Y; Brodovicz KG
    Pharmacoepidemiol Drug Saf; 2016 Dec; 25(12):1375-1386. PubMed ID: 27193175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher Waist Circumference, Fasting Hyperinsulinemia And Insulin Resistance Characterize Hypertensive Patients With Impaired Glucose Metabolism.
    De Pergola G; Nardecchia A; Cirillo M; Boninfante B; Sciaraffia M; Giagulli VA; Triggiani V; Silvestris F
    Endocr Metab Immune Disord Drug Targets; 2015; 15(4):297-301. PubMed ID: 25944063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension and overweight associated with hyperinsulinaemia and glucose tolerance: a longitudinal study of the Finnish and Dutch cohorts of the Seven Countries Study.
    Feskens EJ; Tuomilehto J; Stengård JH; Pekkanen J; Nissinen A; Kromhout D
    Diabetologia; 1995 Jul; 38(7):839-47. PubMed ID: 7556987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma glucose levels as predictors of diabetes: the Mexico City diabetes study.
    Ferrannini E; Massari M; Nannipieri M; Natali A; Ridaura RL; Gonzales-Villalpando C
    Diabetologia; 2009 May; 52(5):818-24. PubMed ID: 19224196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study.
    Hanefeld M; Koehler C; Fuecker K; Henkel E; Schaper F; Temelkova-Kurktschiev T;
    Diabetes Care; 2003 Mar; 26(3):868-74. PubMed ID: 12610051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and metabolomic predictors of regression to normoglycemia in a population at intermediate cardiometabolic risk.
    Sevilla-González MDR; Merino J; Moreno-Macias H; Rojas-Martínez R; Gómez-Velasco DV; Manning AK
    Cardiovasc Diabetol; 2021 Feb; 20(1):56. PubMed ID: 33639941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of chronic kidney disease in young adults with impaired glucose tolerance/impaired fasting glucose: a retrospective cohort study using electronic primary care records.
    Jadhakhan F; Marshall T; Ryan R; Gill P
    BMC Nephrol; 2018 Feb; 19(1):42. PubMed ID: 29482513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertriglyceridemia is associated with development of metabolic glucose disorders, irrespective of glucose and insulin levels: a 15-year follow-up study.
    Guerrero-Romero F; Rodríguez-Moran M
    Eur J Intern Med; 2014 Mar; 25(3):265-9. PubMed ID: 24507408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased serum concentrations of 25-hydroxycholecalciferol are associated with increased risk of progression to impaired fasting glucose and diabetes.
    Tsur A; Feldman BS; Feldhammer I; Hoshen MB; Leibowitz G; Balicer RD
    Diabetes Care; 2013 May; 36(5):1361-7. PubMed ID: 23393216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.